These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6442216)

  • 1. Antimycobacterial activity of rifaximin (L/105) in experimental tuberculosis in the guinea pig.
    Lucchesi M; Marchi E; Venturini AP
    Chemioterapia; 1984 Dec; 3(6):371-2. PubMed ID: 6442216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity to rifaximin and rifampicin of Mycobacterium tuberculosis isolated from guinea pigs treated orally with rifaximin.
    Malvisi Stracciari J; Venturini AP; Anfossi P; Marchi E; Stracciari GL
    Chemioterapia; 1987 Apr; 6(2):82-4. PubMed ID: 3109750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rifamycins, Alone and in Combination.
    Rothstein DM
    Cold Spring Harb Perspect Med; 2016 Jul; 6(7):. PubMed ID: 27270559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of rifaximin on indomethacin-induced intestinal damage in guinea-pigs.
    Ciobanu L; Taulescu M; Prundus R; Diaconu B; Andreica V; Catoi C; Pascu O; Tantau M
    Eur Rev Med Pharmacol Sci; 2014; 18(3):344-51. PubMed ID: 24563433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood, tissue and lesion levels of R AMP in the guinea pig infected with Mycobacterium tuberculosis].
    Blasi A; Ninni A; Olivieri D; Caputi M
    G Ital Mal Torace; 1971; 25(6):283-7. PubMed ID: 5005061
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental research on the antimycobacterial activity of rifampicine: 3-(4-methyl-l-piperazinyl-iminomethyl)-rifomycin SV].
    Lucchesi M; Mancini P; Zubiani M
    Ann Ist Carlo Forlanini; 1967; 27(2):119-36. PubMed ID: 4973676
    [No Abstract]   [Full Text] [Related]  

  • 7. Rifamycin inhibition of WT and Rif-resistant Mycobacterium tuberculosis and Escherichia coli RNA polymerases in vitro.
    Gill SK; Garcia GA
    Tuberculosis (Edinb); 2011 Sep; 91(5):361-9. PubMed ID: 21704562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rifaximin (L/105), a new topical intestinal antibiotic: pharmacokinetic study after single oral administration of 3H-rifaximin to rats.
    Cellai L; Colosimo M; Marchi E; Venturini AP; Zanolo G
    Chemioterapia; 1984 Dec; 3(6):373-7. PubMed ID: 6529779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies on therapeutic efficacy of a new anti-tuberculous drug, benzoxazinorifamycin, against murine experimental mycobacterial infections: attempt at various regimens and protocols].
    Tomioka H; Saito H
    Kekkaku; 1994 Nov; 69(11):703-10. PubMed ID: 7837724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Behavior of drug-resistant mutants of the H37 Rv tubercular strain in experimental tuberculosis of the guinea pig].
    Aliperta A; Ninni A
    Arch Monaldi; 1972; 27(3):72-9. PubMed ID: 4219271
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of drug resistance of Mycobacterium tuberculosis on the therapeutic results of a drug to which sensitivity is retained(experimental data)].
    Belogurova VP; Ivanitskaia NN
    Antibiotiki; 1970 Feb; 15(2):154-7. PubMed ID: 4986204
    [No Abstract]   [Full Text] [Related]  

  • 12. [The animal experimental study on rifampicin-dependent Mycobacterium tuberculosis].
    Li YL; Luo YA; Zhong M; Chen BW; Shen XB; Su C; Wang GZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Sep; 29(9):617-21. PubMed ID: 17129470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental evaluation of the antimycobacterial activity of rifampicin].
    Ninni A; Scoles E; Iodice F; Razza I
    Arch Tisiol Mal Appar Respir; 1968 Apr; 23(4):315-28. PubMed ID: 4981410
    [No Abstract]   [Full Text] [Related]  

  • 14. Rifaximin: a nonabsorbed oral antibiotic.
    Baker DE
    Rev Gastroenterol Disord; 2005; 5(1):19-30. PubMed ID: 15741929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moxifloxacin for the treatment of HIV-associated tuberculosis in patients with contraindications or intolerance to rifamycins.
    Bonora S; Mondo A; Trentini L; Calcagno A; Lucchini A; Di Perri G
    J Infect; 2008 Jul; 57(1):78-81. PubMed ID: 18550175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the pathogenicity, in the guinea-pig, of strains of mycobacterium tuberculosis resistant to rifampicin].
    Timoşca S; Petreanu V; Labă E; Georgescu M; Martinescu T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):309-14. PubMed ID: 6304844
    [No Abstract]   [Full Text] [Related]  

  • 17. [The virulence of resistance strains of Mycobacterium tuberculosis for guinea pigs and experimental therapeutic effects of antitubercular agents on the animals infected by the resistant strains. II. Experimental therapeutic effect on guinea pigs infected by resistant strains of Mycobacterium tuberculosis].
    Yan BS
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1982 Aug; 5(4):206-8. PubMed ID: 6816558
    [No Abstract]   [Full Text] [Related]  

  • 18. Activity of two long-acting rifamycins, rifapentine and FCE 22807, in experimental murine tuberculosis.
    Dhillon J; Dickinson JM; Guy JA; Ng TK; Mitchison DA
    Tuber Lung Dis; 1992 Apr; 73(2):116-23. PubMed ID: 1643297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile rifaximin concentration after oral administration in patients undergoing cholecystectomy.
    Verardi S; Verardi V
    Farmaco; 1990 Jan; 45(1):131-5. PubMed ID: 2337444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Characteristics of the action of ethambutol in experimental tuberculosis].
    Kozulitsyna TI; Uvarova OA; Korotaev GA
    Probl Tuberk; 1976 Jul; (7):70-5. PubMed ID: 822418
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.